The Distortionary Effects of Government Procurement: Evidence from Medicaid Prescription Drug Purchasing
暂无分享,去创建一个
[1] M. Duggan. Do new prescription drugs pay for themselves? The case of second-generation antipsychotics. , 2005, Journal of health economics.
[2] Amy N. Finkelstein. Static and Dynamic Effects of Health Policy: Evidence from the Vaccine Industry , 2004 .
[3] Dawn M Gencarelli. Average wholesale price for prescription drugs: is there a more appropriate pricing mechanism? , 2002, NHPF issue brief.
[4] J. Currie,et al. Medicaid Expansions and Welfare Contractions: Offsetting Effects on Prenatal Care and Infant Health? , 2000, Journal of health economics.
[5] J. Gruber,et al. Public Health Insurance and Private Savings , 1999 .
[6] D Parker,et al. THE PERFORMANCE OF BAA BEFORE AND AFTER PRIVATISATION. A DEA STUDY , 1999 .
[7] D Parker,et al. THE PERFORMANCE OF BAA BEFORE AND AFTER PRIVATIZATION , 1999 .
[8] J. Gruber,et al. Public Health Insurance and Private Savings , 1997, Journal of Political Economy.
[9] J. Borrell. Pharmaceutical price regulation. A study on the impact of the rate-of-return regulation in the UK. , 1999, PharmacoEconomics.
[10] Aaron Yelowitz. Why Did the Ssi-Disabled Program Grow so Much? Disentangling the Effect of Medicaid , 1997, Journal of health economics.
[11] M. Olson. Substitution in Regulatory Agencies: Fda Enforcement Alternatives , 1996 .
[12] Fiona M. Scott Morton. The Strategic Response by Pharmaceutical Firms to the Medicaid Most-Favored-Customer Rules , 1997 .
[13] Aaron Yelowitz,et al. Institute for Research on Poverty Discussion Paper no. 1084-96 The Medicaid Notch, Labor Supply, and Welfare Participation: Evidence from Eligibility Expansions , 1996 .
[14] D. Salkever,et al. "Generic Entry and the Pricing of Pharmaceuticals" , 1995 .
[15] J. Gruber,et al. Does Public Insurance Crowd Out Private Insurance? , 1995 .
[16] J. Laffont,et al. A Theory of Incentives in Procurement and Regulation , 1993 .
[17] David S. Salkever,et al. Pricing, Patent Loss and the Market for Pharmaceuticals , 1991 .
[18] Paul R. Milgrom,et al. Multitask Principal–Agent Analyses: Incentive Contracts, Asset Ownership, and Job Design , 1991 .
[19] George Hendrikse,et al. The Theory of Industrial Organization , 1989 .
[20] Jerome L. Stein,et al. Behavior of the Firm Under Regulatory Constraint , 1972 .